Sino Biopharmaceutical Limited (HKG:1177)

Hong Kong · Delayed Price · Currency is HKD

6.17

+0.04 (0.65%)

At close: Mar 9, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Modernised Chinese Medicines and Chemical Medicines	28.46B	25.77B	25.48B	26.23B	23.09B
Modernised Chinese Medicines and Chemical Medicines Growth	10.44%	1.15%	-2.87%	13.61%	-2.47%
Others	404.43M	428.11M	548.75M	630.69M	559.08M
Others Growth	-5.53%	-21.98%	-12.99%	12.81%	-0.52%
Total	28.87B	26.20B	26.03B	26.86B	23.65B
Total Growth	10.18%	0.67%	-3.11%	13.59%	-2.42%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Mainland China	28.87B	26.20B	26.03B	26.86B	23.65B
Mainland China Growth	10.18%	0.67%	-3.11%	13.59%	-2.42%
Total	28.87B	26.20B	26.03B	26.86B	23.65B
Total Growth	10.18%	0.67%	-3.11%	13.59%	-2.42%

Source: S&P Global Market Intelligence.